Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Braeburn
AddedFeb 15, 2024
UpdatedJun 18, 2026
Braeburn

Braeburn

Braeburn Pharmaceuticals: Providing therapeutic solutions for opioid disorders in Pennsylvania.

HQ
Plymouth Meeting, PA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Braeburn Pharmaceuticals was founded with a mission to provide innovative therapeutic solutions for opioid use disorder. The company focuses on addressing chronic brain diseases and offers comprehensive treatment options, including counseling and support services. Their flagship product, BRIXADI™, is designed to aid in the treatment of opioid addiction. Braeburn primarily serves the Pennsylvania market, aiming to improve patient outcomes and support recovery journeys.

Notable individuals affiliated with Braeburn include experts in the fields of addiction treatment and pharmaceutical development. The company has garnered significant investment to advance its research and development pipeline. Key achievements include the successful launch of BRIXADI™ and contributions to numerous publications and conference abstracts. Braeburn's impact is evident in its commitment to patient care and its role in combating the opioid crisis through effective therapeutic interventions.

Braeburn - Similar Companies

Bridge Therapeutics logo

Bridge Therapeutics

Therabron Therapeutics logo

Therabron Therapeutics

therabron.com

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Brii Biosciences logo

Brii Biosciences

briibio.com

Proniras logo

Proniras

proniras.com

Trevena logo

Trevena

Embera Neurotherapeutics logo

Embera Neurotherapeutics

emberaneuro.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

PleoPharma logo

PleoPharma

pleopharma.com

Bryn Pharma logo

Bryn Pharma

brynpharma.com

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

Assertio Holdings logo

Assertio Holdings

Phoenix PharmaLabs logo

Phoenix PharmaLabs

Chase Therapeutics logo

Chase Therapeutics

Brace Pharma logo

Brace Pharma

bracepharma.com

Braeburn - Quick Facts

Who are Braeburn's competitors?

Companies similar to Braeburn include Bridge Therapeutics, Therabron Therapeutics, Tremeau Pharmaceuticals and Brii Biosciences.

When was Braeburn founded?

Braeburn was founded in 2012.

Where is Braeburn's headquarters located?

Braeburn's headquarters is located in Plymouth Meeting, PA, US.

When was Braeburn's last funding round?

Braeburn's most recent funding round was for $110M (USD) in January 2018.

How much has Braeburn raised to-date?

As of Jan 10, 2018, Braeburn has raised a total of $133M (USD).

How many employees does Braeburn have?

Braeburn has 30 employees as of Feb 5, 2024.

Braeburn - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutics
  • Treatment
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research